Your browser doesn't support javascript.
loading
An in-silico approach to identify the potential hot spots in SARS-CoV-2 spike RBD to block the interaction with ACE2 receptor.
Stalin, Antony; Lin, Ding; Senthamarai Kannan, Balakrishnan; Feng, Yue; Wang, Yanjing; Zhao, Wei; Ignacimuthu, Savarimuthu; Wei, Dong-Qing; Chen, Yuan.
Afiliação
  • Stalin A; State Key Laboratory of Subtropical Silviculture, Department of Traditional Chinese Medicine, Zhejiang A&F University, Hangzhou, China.
  • Lin D; State Key Laboratory of Subtropical Silviculture, Department of Traditional Chinese Medicine, Zhejiang A&F University, Hangzhou, China.
  • Senthamarai Kannan B; Department of Chemistry, Tirunelveli Dakshinamara Nadar Sangam (T D M N S) College, Tirunelveli, Tamil Nadu, India.
  • Feng Y; College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, China.
  • Wang Y; State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint International Research Laboratory of Metabolic & Developmental Sciences and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P.
  • Zhao W; State Key Laboratory of Subtropical Silviculture, Department of Traditional Chinese Medicine, Zhejiang A&F University, Hangzhou, China.
  • Ignacimuthu S; St. Xavier Research Foundation, St. Xavier's College, Tirunelveli, Tamil Nadu, India.
  • Wei DQ; State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint International Research Laboratory of Metabolic & Developmental Sciences and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P.
  • Chen Y; Peng Cheng Laboratory, Shenzhen, Guangdong, P.R China.
J Biomol Struct Dyn ; 40(16): 7408-7423, 2022 10.
Article em En | MEDLINE | ID: mdl-33685364

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: J Biomol Struct Dyn Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: J Biomol Struct Dyn Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China